Video

Q&A With David Shavelle, MD, From the University of Southern California: Updating the Guidelines for Acute Coronary Syndromes

Author(s):

As new medications and agents are developed organizations like the American College of Cardiology and the American Heart Association update their guidelines on treating a variety of conditions. Recently work was completed to help doctors treating acute coronary syndromes.

As new medications and agents are developed organizations like the American College of Cardiology and the American Heart Association update their guidelines on treating a variety of conditions. Recently work was completed to help doctors treating acute coronary syndromes.

David Shavelle, MD, from the University of Southern California discussed what the new guidelines mean for treatment and also some new medications that doctors can prescribe their patients during the American College of Physicians Internal Medicine meeting in Boston. Shavelle said in some cases the new medications could be used instead of the more commonly used and popular clopidogrel even as further studies are conducted.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.